Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.5 to v3.6.6, indicating a newer version of the page without changing the trial details.
    Difference
    0.0%
    Check dated 2026-09-03T18:41:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The added text '2017 ( U.S. NIH Grant/Contract )' appears in the Study ID Numbers area, indicating NIH funding for the trial.
    Difference
    0.0%
    Check dated 2026-08-27T17:26:38.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5. This indicates a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-08-13T10:11:56.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3 label and indicating an updated version of the content.
    Difference
    0.0%
    Check dated 2026-07-23T05:43:27.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing v3.6.0. This indicates a minor update to the page's revision history/documentation rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-01T12:27:41.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, and it notes that recruitment is closed ('No longer looking for participants') with a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T05:33:43.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.